Toggle Main Menu Toggle Search

Open Access padlockePrints

The association between early diagnosis of gestational diabetes and maternal-neonatal outcomes: a secondary analysis of the digest trial

Lookup NU author(s): Professor Roy Taylor

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© The Author(s) 2026.Purpose: To determine whether early gestational diabetes (GDM) differs from later GDM in maternal characteristics and perinatal outcomes. Methods: This is a secondary analysis of an energy-restricted dietary intervention in GDM (DiGest) randomized controlled trial. We compared maternal weight, glycemia, and pregnancy/neonatal outcomes between the early GDM (< 20 weeks, n = 118) and standard GDM diagnosis (21–28 weeks, n = 299) groups. Results: Early GDM was associated with higher antenatal (40 vs. 38 mmol/mol; p = 0.017) and postnatal HbA1c (38 vs. 36 mmol/mol; p = 0.002) and higher risk of diabetes/prediabetes postnatally (19 vs. 6%; p = 0.003). Despite higher medication requirements, perinatal outcomes did not differ. Lower gestational weight gain (2.5 vs. 5.3 kg, p = 0.003) and comparable glycemia at 36 weeks were found. Timing of diagnosis did not impact the effect of the DiGest intervention. Conclusion: Early GDM reflects more severe underlying hyperglycemia, but timely treatment and reduced gestational weight gain can offset adverse perinatal risks.


Publication metadata

Author(s): Dib S, Luo N, Jones DL, Smith S, Taylor R, Murphy HR, Kusinski LC, Meek CL

Publication type: Article

Publication status: Published

Journal: Endocrine

Year: 2026

Volume: 91

Issue: 1

Online publication date: 16/02/2026

Acceptance date: 20/12/2025

Date deposited: 02/03/2026

ISSN (print): 1355-008X

ISSN (electronic): 1559-0100

Publisher: Springer

URL: https://doi.org/10.1007/s12020-025-04542-y

DOI: 10.1007/s12020-025-04542-y

Data Access Statement: The datasets generated during and/or analyzed in the current study are available from the corresponding author upon reasonable request.

PubMed id: 41697463


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Cambridge Biomedical Research Centre
Diabetes UK
Leicester Biomedical Research Centre
National Institute for Health Research
Novo Nordisk Foundation Future Leaders’ Award (NNF19SA058974)

Share